Understanding Esophageal Adenocarcinoma Prognosis with a Gene Signature
Author Information
Author(s): Fu Haijing, Liu Mengyan, Li Huiyu, Yu Li, Song Haizhu, Chu Xiaoyuan, Bao Wei
Primary Institution: Nanjing Medical University
Hypothesis
The study aims to identify PANoptosis-related genes that can serve as reliable prognostic markers for esophageal adenocarcinoma (EAC).
Conclusion
The study presents a validated risk scoring model and prognostic nomogram that can effectively predict patient outcomes in EAC.
Supporting Evidence
- The prognostic risk score model effectively predicts patient outcomes.
- Functional analyses revealed significant biological processes associated with high-risk EAC.
- Immune infiltration analysis identified distinct immune profiles between risk groups.
Takeaway
Researchers found a way to predict how well patients with esophageal cancer might do based on certain genes, which can help doctors choose the best treatments.
Methodology
The study used bioinformatics analysis of TCGA, GTEx, and GEO datasets to identify PANoptosis-related genes and developed a prognostic risk score model based on 8 significant genes.
Potential Biases
Potential biases may arise from sample handling, technology platforms, and individual patient characteristics affecting gene expression.
Limitations
The study's findings require further validation in larger, prospective, and multi-center studies due to potential inconsistencies in gene expression and technical factors.
Participant Demographics
The study analyzed 720 samples, including 88 EAC samples and 652 normal esophageal samples.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%CI=3.35~14.2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website